First Results of the BEYOND Phase II Study of Luspatercept (Reblozyl (R)) in adult Patients with non-transfusion-dependent Beta-Thalassemia presented at EHA Congress 2021-MedSci.cn

First Results of the BEYOND Phase II Study of Luspatercept (Reblozyl (R)) in adult Patients with non-transfusion-dependent Beta-Thalassemia presented at EHA Congress 2021

[Anonymous]

ONCOLOGY RESEARCH AND TREATMENT, 2021; 44 (7-8): 430

科室
- - 订阅+
  - 更多科室
工具
服务